We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFYA icon
526
Afya
AFYA
$1.27B
$964K 0.07%
54,612
+37,963
+228% +$661K
CTBI icon
527
Community Trust Bancorp
CTBI
$1.41B
$964K 0.07%
22,081
+15,067
+215% +$633K
IDT icon
528
IDT Corp
IDT
$1.62B
$963K 0.07%
+26,812
New +$1.01M
B
529
Barrick Mining
B
$73.2B
$962K 0.07%
57,703
-45,519
-44% -$773K
MRX
530
Marex Group Limited Ordinary Shares
MRX
$4.37B
$961K 0.07%
+48,031
New +$944K
ML
531
DELISTED
MoneyLion Inc.
ML
$961K 0.07%
13,067
-5,156
-28% -$405K
INN
532
Summit Hotel Properties
INN
$700M
$957K 0.07%
+159,720
New +$977K
FLEX icon
533
Flex
FLEX
$44.8B
$956K 0.07%
32,418
-32,232
-50% -$965K
MLTX icon
534
MoonLake Immunotherapeutics
MLTX
$1.55B
$955K 0.07%
+21,724
New +$920K
UNF icon
535
Unifirst Corp
UNF
$5.25B
$954K 0.07%
+5,559
New +$897K
WBD icon
536
Warner Bros
WBD
$67.1B
$954K 0.07%
128,242
+16,070
+14% +$129K
USAP
537
DELISTED
Universal Stainless & Alloy
USAP
$954K 0.07%
34,832
-879
-2% -$25.9K
DOC icon
538
Healthpeak Properties
DOC
$14.8B
$951K 0.07%
+48,514
New +$927K
LAND
539
Gladstone Land Corp
LAND
$360M
$949K 0.07%
69,320
-1,063
-2% -$14K
MYRG icon
540
MYR Group
MYRG
$5.25B
$949K 0.07%
6,994
+4,309
+160% +$673K
F icon
541
Ford
F
$55.7B
$947K 0.07%
75,549
+42,259
+127% +$523K
UAA icon
542
Under Armour
UAA
$2.6B
$947K 0.07%
142,001
+110,193
+346% +$751K
ALGN icon
543
Align Technology
ALGN
$12.3B
$946K 0.07%
3,920
+3,301
+533% +$919K
AXTA icon
544
Axalta
AXTA
$8.17B
$945K 0.07%
27,652
+2,140
+8% +$73.2K
PTCT icon
545
PTC Therapeutics
PTCT
$6.12B
$944K 0.07%
30,858
+17,151
+125% +$556K
AAT
546
American Assets Trust
AAT
$1.4B
$939K 0.07%
+41,937
New +$902K
HUYA
547
Huya Inc
HUYA
$558M
$939K 0.07%
+237,686
New +$1.12M
WSC icon
548
WillScot Mobile Mini Holdings
WSC
$4.41B
$937K 0.07%
24,881
-20,445
-45% -$809K
DNA icon
549
Ginkgo Bioworks
DNA
$521M
$935K 0.07%
+69,887
New +$2.09M
SMP icon
550
Standard Motor Products
SMP
$911M
$934K 0.07%
33,681
+21,313
+172% +$663K

Similar funds

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.